ARCHIVES

Attacks On Cancer, Program Peak Following Post Series; Defenders Cite Inaccuracies, Misconceptions

This article is from The Cancer Letter archive.

Vol. 07 No. 45 | November 6, 1981

Download PDF Visit The Full Archive

Related Articles

Administration Plans to Stop Paying Advisors; NIH, HHS to Make Protest

May 6, 1983

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

April 25, 2013

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014